...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: you won’t see anyone buying this

tada, approx 20,000,000 warrants (unexercised) are included in the fully diluted figure of 184,683,974. So it's more like a ~ 20% dilution in ~2.5 years or 8% per year for this period. 

 

Koo   

Share
New Message
Please login to post a reply